Back to Man Group plc Man Group plc

KNSAKNSA
8 quarters

Position history for Man Group plcMan Group plc's holdings in KINIKSA PHARMACEUTICALS INTE

Yes. Man Group holds 40,524 shares of KNSA (Kiniksa Pharmaceuticals Inte), worth $2.6M, as of its Q2 2026 13F filing. It reduced the position by 86,662 shares (-68.1%) from Q1 2026. Man Group has held KNSA since Q3 2025, across 4 quarterly 13F filings.

Current Value

$2.6M

Current Shares

40,524

Total Value Change

+$2.4M

Total Shares Change

+32,499

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Decreased
40,524
-68.1%
$2.6M0.0%$63.95
0
2026-Q1
Increased
127,186
+222.4%
$6.1M0.0%$48.15
44
2025-Q4
Decreased
39,447
-41.9%
$1.6M0.0%$41.25
0
2025-Q3
New
67,905
-
$2.6M0.0%$38.83
36
2025-Q2
Exited
0
-100.0%
$00.0%$27.67
0
2025-Q1
New
9,121
-
$202,5770.0%$22.21
32
2024-Q4
Exited
0
-100.0%
$00.0%$19.78
0
2024-Q3
New
8,025
-
$200,5450.0%$24.99
32

Other major holders of KNSA: FMR LLC, BAKER BROS. ADVISORS LP, BlackRock, Inc.

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used